Total Payments
$801.65
2024 Payments
$144.25
Companies
9
Transactions
12
Medicare Patients
5,761
Medicare Billing
$915,425
Payment Breakdown by Category
Food & Beverage$801.65 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $801.65 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $204.38 | 2 | $0 (2018) |
| Melinta Therapeutics, Inc. | $190.23 | 2 | $0 (2018) |
| AngioDynamics, Inc. | $147.14 | 1 | $0 (2022) |
| Shionogi Inc | $117.32 | 1 | $0 (2024) |
| AbbVie Inc. | $53.49 | 2 | $0 (2021) |
| Insmed, Inc. | $26.93 | 1 | $0 (2024) |
| Allergan Inc. | $23.43 | 1 | $0 (2018) |
| Janssen Biotech, Inc. | $20.47 | 1 | $0 (2023) |
| Amneal Pharmaceuticals LLC | $18.26 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $144.25 | 2 | Shionogi Inc ($117.32) |
| 2023 | $38.73 | 2 | Janssen Biotech, Inc. ($20.47) |
| 2022 | $147.14 | 1 | AngioDynamics, Inc. ($147.14) |
| 2021 | $53.49 | 2 | AbbVie Inc. ($53.49) |
| 2018 | $320.33 | 4 | Melinta Therapeutics, Inc. ($190.23) |
| 2017 | $97.71 | 1 | Merck Sharp & Dohme Corporation ($97.71) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/30/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $117.32 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/21/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: Respiratory | ||||||
| 10/18/2023 | Amneal Pharmaceuticals LLC | ALYMSYS (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2023 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $20.47 | General |
| 06/22/2022 | AngioDynamics, Inc. | AURYON LASER SYSTEM 100-120 VAC (Device) | Food and Beverage | In-kind items and services | $147.14 | General |
| Category: PAD | ||||||
| 11/03/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/16/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/23/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/05/2018 | Melinta Therapeutics, Inc. | Baxdela (Drug) | Food and Beverage | Cash or cash equivalent | $119.80 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/08/2018 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Food and Beverage | In-kind items and services | $106.67 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/27/2018 | Melinta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $70.43 | General |
| 02/23/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $97.71 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,405 | 2,849 | $402,565 | $207,375 |
| 2022 | 7 | 1,473 | 3,012 | $426,121 | $215,958 |
| 2021 | 6 | 1,410 | 2,902 | $425,242 | $215,427 |
| 2020 | 7 | 1,473 | 3,962 | $523,538 | $276,665 |
Total Patients
5,761
Total Services
12,725
Medicare Billing
$915,425
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 593 | 1,682 | $172,191 | $99,607 | 57.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 392 | 409 | $115,903 | $53,009 | 45.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 286 | 462 | $68,240 | $41,232 | 60.4% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Facility | 2023 | 64 | 220 | $31,447 | $5,920 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 48 | $8,772 | $4,530 | 51.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,106 | $1,607 | 51.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $2,907 | $1,470 | 50.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 601 | 1,874 | $191,706 | $100,453 | 52.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 438 | 452 | $128,549 | $67,396 | 52.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 268 | 404 | $59,388 | $31,273 | 52.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 90 | $16,448 | $8,600 | 52.3% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Facility | 2022 | 53 | 159 | $22,732 | $4,401 | 19.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $4,778 | $2,514 | 52.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $2,519 | $1,321 | 52.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 578 | 1,740 | $186,579 | $96,152 | 51.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 395 | 415 | $123,661 | $63,479 | 51.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 299 | 529 | $81,137 | $42,112 | 51.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 67 | 86 | $13,753 | $8,394 | 61.0% |
| 97597 | Removal of tissue from wounds per session, first 20 sq cms or less | Facility | 2021 | 50 | 111 | $15,870 | $3,107 | 19.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 21 | 21 | $4,242 | $2,184 | 51.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 739 | 3,126 | $335,318 | $176,444 | 52.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 363 | 376 | $112,029 | $59,870 | 53.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 169 | 246 | $37,688 | $20,209 | 53.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 123 | 124 | $24,975 | $13,093 | 52.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 51 | 61 | $9,551 | $5,053 | 52.9% |
About Dr. Vijay Kolli, MD
Dr. Vijay Kolli, MD is a Infectious Disease healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013017292.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vijay Kolli, MD has received a total of $801.65 in payments from pharmaceutical and medical device companies, with $144.25 received in 2024. These payments were reported across 12 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($801.65).
As a Medicare-enrolled provider, Kolli has provided services to 5,761 Medicare beneficiaries, totaling 12,725 services with total Medicare billing of $915,425. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Oklahoma City, OK
- Active Since 09/25/2006
- Last Updated 01/16/2025
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1013017292
Products in Payments
- AURYON LASER SYSTEM 100-120 VAC (Device) $147.14
- Baxdela (Drug) $119.80
- Fetroja (Drug) $117.32
- ZINPLAVA (Biological) $106.67
- ZERBAXA (Drug) $97.71
- DALVANCE (Drug) $53.49
- Arikayce (Drug) $26.93
- AVYCAZ (Drug) $23.43
- ALYMSYS (Drug) $18.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Oklahoma City
Ahmad Ashfaq, M.d, M.D
Infectious Disease — Payments: $40,066
Infectious Disease $40,066
David Chansolme, Md, MD
Infectious Disease — Payments: $2,777
Infectious Disease $2,777
Dr. Janki Amin, M.d, M.D
Infectious Disease — Payments: $2,575
Infectious Disease $2,575
Cade Parke, D.o, D.O
Infectious Disease — Payments: $1,860
Infectious Disease $1,860
Dr. John Harkess, Md, MD
Infectious Disease — Payments: $1,857
Infectious Disease $1,857
Dr. Thara Rani Damodaran, M.d, M.D
Infectious Disease — Payments: $261.13
Infectious Disease $261.13